GTCR, a private equity firm, has invested in PathGroup Holdings LLC.
GTCR’s investment supports PathGroup as the firm grows through expansion of laboratories into Texas and other regions. GTCR has expertise in the healthcare and lab testing industries and will leverage its resources to help support the growth of PathGroup.
“Dr. Davis and the PathGroup team have done an incredible job of building PathGroup into a unique, scaled lab services business with outstanding clinical services,” said Sean Cunningham, managing director at GTCR. “We look forward to supporting the team and expanding the PathGroup platform through organic growth initiatives and additional strategic acquisitions.”
Latham & Watkins provided legal counsel to GTCR. BofA Securities and Nomura Securities served as financial advisors and Kirkland & Ellis served as legal advisor to PathGroup.